Latin America stands out as a top destination for high-quality clinical trials. With extensive experience in the region, we offer the expertise needed to navigate local nuances and successfully implement clinical research strategies.
Diverse Population
Latin America offers access to more than 650 million people with diverse genetic histories and health profiles, essential elements for conducting inclusive and representative clinical studies. This diversity allows for the collection of comprehensive data, benefiting the validity and applicability of results.
Established Research Traditions
Countries such as Argentina, Mexico, and Brazil have well-developed clinical research infrastructures. For example, Brazil conducted over 300 clinical trials in 2023 alone, demonstrating its continued commitment to scientific research. These countries have a proven track record of participating in global studies, ensuring a stable and reliable regulatory environment.
Emerging Research Centers
Colombia and Panama are rapidly gaining recognition for their clinical research potential. Significant investments in healthcare infrastructure are propelling these countries into emerging research hubs, offering opportunities for expanding clinical trials in innovative settings.
Proven Track Record During COVID-19
During the COVID-19 pandemic, Latin American countries have played crucial roles in global vaccine trials, contributing significantly to vaccine development and validation. This experience has strengthened the region’s capacity to conduct research of high global relevance.
Reputable Regulatory Authorities
Regulatory bodies such as ANMAT in Argentina and ANVISA in Brazil advocate rigorous research standards. ANVISA, in particular, sits on the ICH board of directors, which highlights its influence on global pharmaceutical regulations. These bodies ensure that clinical trials follow international standards of quality and safety.
Cost-Effective Region
Clinical trials in Latin America can be up to 30% more cost-effective than in North America or Europe, providing significant budgetary advantages without compromising quality. This cost-effectiveness makes the region an attractive destination for clinical trial sponsors.
Highly Qualified Researchers
The region is home to a large number of medical professionals experienced in conducting clinical trials. In Brazil alone, there are over 20,000 qualified researchers, ensuring that studies are conducted with the highest technical competence.
Significant Pharmaceutical Market
Brazil is the sixth largest pharmaceutical market in the world, with a market value expected to exceed US$30 billion by 2023. Argentina and Mexico also have substantial pharmaceutical markets, with consistent year-on-year growth, providing a favorable environment for research and development of new medicines.
Advanced Clinical Infrastructure
With over 6,500 hospitals and numerous specialized clinical research facilities, Brazil and Argentina offer a robust infrastructure for conducting clinical trials. This advanced infrastructure facilitates the efficient execution of large-scale, complex studies.
Availability of Real-World Data Assets
The integration of broad health data systems, such as the Unified Health System (SUS) in Brazil, provides researchers with access to real and comprehensive data sets. These data are valuable for conducting robust analyses and obtaining relevant clinical insights.
Accelerated Recruitment
Clinical trial centers in Latin America have demonstrated the ability to enroll participants up to 50% faster than centers in other regions. This recruitment efficiency significantly reduces study timelines, accelerating the time needed to obtain results and commercialize new treatments.
The combination of a diverse population, well-established research traditions, emerging research centers, and advanced clinical infrastructure positions Latin America as an ideal destination for conducting high-quality clinical trials. With a proven track record and robust infrastructure, the region offers a favorable and cost-effective environment for conducting clinical research that can impact health and medicine globally.
コメント